Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

Researchers at Durham University, in collaboration with international partners, have developed a robotic system that allows ...

Patients who go to the doctor to provide a blood sample are typically faced with a needle and syringe and hours or days of ...

Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with ...

Abbott Laboratories ABT reported third-quarter 2024 adjusted earnings per share (EPS) of $1.21, which beat the Zacks ...

There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

The smart contact lenses, which are currently in advanced stages of testing, represent a major shift in how healthcare can be ...

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...